Immix Biopharma Stock Price on October 16, 2024
| IMMX Stock | USD 1.79 0.11 6.55% |
If you're considering investing in Immix Stock, it is important to understand the factors that can impact its price. As of today, the current price of Immix Biopharma stands at 1.79, as last reported on the 22nd of November, with the highest price reaching 1.79 and the lowest price hitting 1.60 during the day. Immix Biopharma holds Efficiency (Sharpe) Ratio of -0.0257, which attests that the entity had a -0.0257% return per unit of risk over the last 3 months. Immix Biopharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immix Biopharma's Standard Deviation of 5.47, market risk adjusted performance of (0.25), and Risk Adjusted Performance of (0.04) to validate the risk estimate we provide.
Stock Based Compensation is likely to rise to about 2.7 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 8.6 M in 2024. . At this time, Immix Biopharma's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 7.68 in 2024, whereas Price To Sales Ratio is likely to drop (0.32) in 2024. Immix Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Immix |
Sharpe Ratio = -0.0257
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | IMMX |
Estimated Market Risk
| 5.6 actual daily | 49 51% of assets are more volatile |
Expected Return
| -0.14 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Immix Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immix Biopharma by adding Immix Biopharma to a well-diversified portfolio.
Price Book 2.6331 | Book Value 0.823 | Enterprise Value 27.6 M | Enterprise Value Ebitda (0.37) | Shares Float 14.5 M |
Related Headline
AVROBIO Headline on 20th of June 2024
Tectonic, AVROBIO complete merger, announce 130.7M private p... by seekingalpha.com
Tectonic Therapeutic announced the closing of its planned merger with AVROBIO , along with a concurrent 130.7 private placement. Read more here.
Immix Biopharma Valuation on October 16, 2024
It is possible to determine the worth of Immix Biopharma on a given historical date. On October 16, 2024 Immix was worth 1.46 at the beginning of the trading date compared to the closed value of 1.44. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immix Biopharma stock. Still, in general, we apply an absolute valuation method to find Immix Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immix Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immix Biopharma's related companies.
| Open | High | Low | Close | Volume | |
| 1.37 | 1.54 | 1.36 | 1.46 | 245,870 | |
10/16/2024 | 1.46 | 1.51 | 1.39 | 1.44 | 99,575 |
| 1.46 | 1.99 | 1.46 | 1.69 | 383,505 |
| Backtest Immix Biopharma | | | Immix Biopharma History | | | Immix Biopharma Valuation | Previous | Next |
Immix Biopharma Trading Date Momentum on October 16, 2024
| On October 17 2024 Immix Biopharma was traded for 1.69 at the closing time. The top price for the day was 1.99 and the lowest listed price was 1.46 . The trading volume for the day was 383.5 K. The trading history from October 17, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 17.36% . The trading delta at closing time against the current closing price is 17.36% . |
Immix Biopharma Fundamentals Correlations and Trends
By evaluating Immix Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immix Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immix financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immix Biopharma Stock history
Immix Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immix is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immix Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immix Biopharma stock prices may prove useful in developing a viable investing in Immix Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 17.3 M | 13.1 M | |
| Net Loss | -7.4 M | -7.8 M |
Immix Biopharma Stock Technical Analysis
Immix Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immix Biopharma Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Immix Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Immix Biopharma November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Immix Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immix Biopharma shares will generate the highest return on investment. By undertsting and applying Immix Biopharma stock market strength indicators, traders can identify Immix Biopharma entry and exit signals to maximize returns
Immix Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immix Biopharma's price direction in advance. Along with the technical and fundamental analysis of Immix Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immix to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.45) | |||
| Total Risk Alpha | (1.04) | |||
| Treynor Ratio | (0.26) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Immix Stock Analysis
When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.